新型茛菪烷类化合物对豚鼠回肠肌M受体动力学研究

目的探讨定向合成新型莨菪烷类化合物对豚鼠回肠肌M受体动力学的作用。方法采用豚鼠离体回肠纵肌累积剂量-效应曲线法,求得pD2(解离常数负对数)及Emax(最大效应)值,以乙酰胆碱(ACh)为标准品,比较其亲和力和内在活性。结果MAC-6、MAC-7、MAC-8、MAC-18和MAC-19化合物与豚鼠肠纵肌M受体具有不同程度的亲和力(pD2＝6．59～8．77),引起豚鼠肠纵肌收缩最大效应为ACh的29％～57％,选择性M受体拮抗药阿托品能阻断其作用;相反,MAC-16能显著抑制由ACh引起豚鼠肠纵肌收缩,呈竞争性拮抗作用,其pA2为7．72。结论　定向合成莨菪烷类化合物具有明显的M受体激动或阻断作用,并显示明显的构效关系特征。     

Selective cortical decrease of high-affinity choline uptake carrier in Alzheimer's disease: An autoradiographic study using3H-hemicholinium-3

Summary ³H-hemicholinium-3 (³H-HC-3) binding, a marker of the presynaptic high-affinity choline uptake carrier (HACU), was measured by autoradiography in several brain regions of 17 Alzheimer's disease (AD) patients and of 11 matched controls. A significant decrease in the density of³H-HC-3 binding sites was found in entorhinal cortex, hippocampus and layers I–III of the frontal cortex. By contrast, in the caudate-putamen the number of³H-HC-3 binding sites in AD cases was comparable to that of control striata. These data concur with previous results using classical presynaptic markers and reflect the loss in the activity of HACU, and, hence, in the synthesis of acetylcholine, that selectively occurs in cortical areas of AD brains due to the degeneration of presynaptic cholinergic terminals arising from the basal forebrain. However, the relatively low mean reduction in HACU in cortical areas (–40%), together with the apparent indemnity of this marker in certain severely demented AD cases, suggest that AD dementia cannot be explained simply by the loss of presynaptic terminals originating in the basal forebrain. These data seem to be a good explanation for the poor response to cholinergic replacement in AD.     

Carrier mediated transport of choline in rat lens

Choline accumulation was studied in rat lenses incubated in TC-199 medium containing radiolabeled choline. Choline entered the lens and was rapidly phosphorylated. Phosphorylcholine did not readily escape the lens and continued to accumulate throughout 24 hr of incubation. Accumulation of choline displayed saturation kinetics and this saturability appeared to be a property of transport rather than a reflection of the properties of choline kinase. Countertransport of labeled choline from lenses preloaded with radiolabeled choline indicates that choline transport in rat lens is carrier mediated. The existence of a choline carrier would also be consistent with the kinetic data. Ethanolamine competed for the choline carrier, however a component of ethanolamine uptake was non-saturable at concentrations of ethanolamine or choline up to 5 mm. Choline and ethanolamine appeared to be phosphorylated by separate kinases in lens.     

Calcium mobilization elicited by two types of nicotinic acetylcholine receptors in mouse substantia nigra pars compacta

Nicotinic acetylcholine receptors (nAChRs) are expressed in the midbrain ascending dopaminergic system, a target of many addictive drugs. Here we assessed the intracellular Ca2+ level by imaging fura-2-loaded cells in substantia nigra pars compacta in mouse brain slices, and we examined the influence on this level of prolonged exposures to nicotine using mice lacking the nAChR beta2-subunit. In control cells, superfusion with nicotine (10-100 microM) caused a long-lasting rise of intracellular Ca2+ level which depended on extracellular Ca2+. This nicotinic response was almost completely absent in beta2-/- mutant mice, leaving a small residual response to a high concentration (100 microM) of nicotine which was inhibited by the alpha7-subunit-selective antagonist, methyllycaconitine. Conversely, the alpha7-subunit-selective agonist choline (10 mM) caused a methyllycaconitine-sensitive increase in intracellular Ca2+ level both in wild-type and beta2-/- mutant mice. Nicotine-elicited Ca2+ mobilization was reduced by the Na+ channel blocker tetrodotoxin (TTX) and by T-type Ca2+ channel blocking agents, whereas the choline-elicited Ca2+ increase was insensitive to TTX. Neither nicotine nor choline produced Ca2+ increase following inhibition of the release of Ca2+ from intracellular stores by dantrolene. These results demonstrate that in nigral dopaminergic neurons, nicotine can elicit Ca2+ mobilization via activation of two distinct nAChR subtypes: that of beta2-subunit-containing nAChR followed by activation of Na+ channel and T-type Ca2+ channels, and/or activation of alpha7-subunit-containing nAChR. The Ca2+ influx due to nAChR activation is subsequently amplified by the recruitment of intracellular Ca2+ stores. This Ca2+ mobilization may possibly contribute to the long-term effects of nicotine on the dopaminergic system.     

Impaired cholinergic function in cell lines derived from the cerebral cortex of normal and trisomy 16 mice

Murine trisomy 16 is an animal model of human Down's syndrome. We have successfully established permanently growing cell lines from the cerebral cortex of normal and trisomy 16 foetal mice using an original procedure. These lines, named CNh (derived from a normal animal) and CTb (derived from a trisomic foetus), express neuronal markers. Considering that Down's syndrome exhibits cholinergic deficits, we examined cholinergic function in these lines, using incorporation of [3H]-choline and fractional release studies. After 1, 3 and 5 min of [3H]-choline incubation, CTb cell uptake was lower by approximately 50% compared to controls. Hemicholinium-3 significantly reduced the incorporation of [3H]-choline in both CNh and CTb cells at high concentration (10 microM), suggesting high-affinity choline transport. However, CTb cells exhibited greater sensitivity to the blocker. For fractional release experiments, the cells were stimulated by K+ depolarization, glutamate or nicotine. When depolarized, CTb cells showed a 68% reduction in fractional release of [3H]-acetylcholine compared to CNh cell line, and a 45% reduction when stimulated by nicotine. Interestingly, glutamate induced similar levels of release in both cell types. The results indicate the existence of cholinergic dysfunction in CTb cells when compared to CNh, similar to that reported for primary cultures of trisomy 16 brain tissue (Fiedler et al. 1994, Brain Res., 658, 27-32). Thus, the CTb cell line may serve as a model for the study of Down's syndrome pathophysiology.     

内皮细胞乙酰胆碱靶标不同于M受体的药理学特征

目的 研究内皮细胞乙酰胆碱靶标与M受体药理学特征的差异。方法 采用离体血管环实验方法,观察抗M_3受体的单克隆抗体和M受体激动剂毛果芸香碱对乙酰胆碱引起的内皮依赖性舒张血管作用的影响。结果 毛果芸香碱能够剂量依赖性拮抗乙酰胆碱诱导的内皮依赖性血管舒张作用,其拮抗性质为非竞争性拮抗;抗M_3受体的单克隆抗体不影响乙酰胆碱诱发的内皮依赖性舒张血管作用,但能拮抗乙酰胆碱诱发的离休肠肌收缩作用。结论 内皮细胞乙酰胆碱靶标的药理学特征不同于经典M受体。     

卵巢切除大鼠降钙素基因相关肽、乙酰胆碱和去甲肾上腺素血管效应的变化(英文)

目的　研究雌性大鼠卵巢切除和雌激素替代治疗 4个月后 ,血管活性物质对离体动脉作用的改变。方法　采用双侧卵巢切除的雌性大鼠 ,分为假手术组、去卵巢组 (8周龄切除双侧卵巢 )和雌激素替代组 (苯甲雌二醇 40 μg,sc ,每日 1次 ,卵巢切除后 1 4d开始给药至切除后 4个月 )。于给药结束时取升主动脉、胸主动脉及尾动脉 ,进行离体血管功能实验 ,观察对降钙素基因相关肽 (CGRP)、乙酰胆碱(ACh)及去甲肾上腺素 (NE)的反应。结果　卵巢切除 4个月使CGRP引起的大鼠升主动脉舒张最大效应明显降低 ,而对胸主动脉无影响 ;同时ACh对胸主动脉的舒张效应曲线明显右移 ,而对升主动脉无影响。雌激素替代治疗使上述变化反转。去卵巢组的各类动脉对NE的反应性无变化 ,而雌激素替代组的升主动脉和胸主动脉对NE引起的最大收缩效应明显降低。在尾动脉 ,去卵巢组和雌激素替代组的CGRP和NE反应性均无改变。结论　内源性雌激素可以通过多种途径调节血管反应性 ,发挥其心血管保护作用。本研究进一步提示对绝经期妇女进行激素替代治疗的重要性     

Study on mechanism of huanshao dan in brain protectionΔin brain protectionΔ

Objective: To observe the behavioral and biochemical effects of a traditional Chinese medicine Huanshao Dan (HSD) on learning and memory deficits in transient cerebral ischemia model in mice.Methods: Step-through experiments, receptor binding test and choline acetyltransferase (ChAT) activities determination were performed.Results: Mice undertaken transient ischemia commited much more mistakes in step-through experiments and showed relatively higher³ H-MK801 binding in cerebral cortex and hippocampus than in sham operated animals. HSD decoction was most effective in reducing these mistakes in mice. At the same time, and³ H-MK801 binding of cerebral cortex and hippocampus tissues were also significantly decreased, while ChAT activities in the same tissues were increased.Conclusion: HSD might antagonize ischemic injury of brain through inhibition of glutamate N-methyl-D-Aspartic acid receptor overactivity. ΔThis program was supported by National Nature Science Foundation of China (No.39421012)     

酶电极法测定氯化琥珀胆碱注射液氯化胆碱及氯化琥珀胆碱含量

 目的：测定氯化琥珀胆碱注射液中氯化胆碱与氯化琥珀胆碱含量。方法：以固定化胆碱氧化酶（EC5896）结合H₂O₂电极构成电流型酶电极生物传感分析仪并与银量法对比测定。结果：酶电极法测定线性范围：0mg·L^－1～200mg·L^－1，精度RSD＜1．5％，响应时间：40s，固定化胆碱氧化酶膜使用寿命大于60d，实际测定氯化琥珀胆碱注射液中氯化胆碱含量；回收率：100．3％～102．3％。与银量法对比测定，两法测定结果的相关系数r＝0．9929。结论：采用酶电极法能准确测定氯化琥珀胆碱注射液中氯化胆碱及氯化琥珀胆碱含量。